Cutaneous malignant melanoma and Parkinson disease: Common pathways? - Wikidata - wikimedia - TriplyDB

Cutaneous malignant melanoma and Parkinson disease: Common pathways?

Cutaneous malignant melanoma and Parkinson disease: Common pathways?

http://www.wikidata.org/entity/Q38985873

about

Biological and Clinical Implications of Comorbidities in Parkinson's Disease.Cutaneous squamous cell carcinoma and the PARK2 gene.Parkinson's Disease and Melanoma: Co-Occurrence and Mechanisms

P2860

Q47137783-4E5598E8-566C-4C3C-BE4B-F9AC858212B0 Q48116562-9B9919E2-0C40-4A87-94CA-ECAB985B8FB7 Q58779911-D6C472EB-11CD-4E21-BDD0-B90670FA6923

P2860

Cutaneous malignant melanoma and Parkinson disease: Common pathways?

http://www.wikidata.org/entity/Q38985873

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Cutaneous malignant melanoma and Parkinson disease: Common pathways?

@en

type

label

Cutaneous malignant melanoma and Parkinson disease: Common pathways?

@en

prefLabel

Cutaneous malignant melanoma and Parkinson disease: Common pathways?

@en

P1433

Q38985873-5E667FA8-90BB-4D95-A580-3CC7D9CC067A

P1476

Q38985873-2246B021-895E-4FEB-B14A-C278C2AA2D84

P2093

Q38985873-03A406D0-338D-450F-A630-DA086DD95480

Q38985873-21DCA653-7121-4C4B-B8E8-7FC8E1000B0B

Q38985873-F684706E-1819-4F45-8B07-7E3111009261

P2860

Q38985873-01DA04FA-B5BD-4A40-80DC-533C4B1F3E2D

Q38985873-03428C8C-760E-4D91-9E30-BE3FB3CA8BEA

Q38985873-072C812E-5CF7-4C8C-829F-CBAD78BC9AA3

Q38985873-09ED1375-06C4-4673-BB43-935787C49B9B

Q38985873-09EDDA95-D605-462B-ADB0-5BFD101BEEC8

Q38985873-0ABAC564-DF08-4015-8537-3EC561C7266C

Q38985873-0B6655CC-FA65-4A1B-AF19-275A468C23B7

Q38985873-0C8D2774-CD96-4DE4-AF46-E731828A622D

Q38985873-0E77F005-D6E6-49AF-82D5-B2B08B7059E3

Q38985873-0E7DABEF-B369-43A9-9170-02ED8389F671

P304

Q38985873-DDD62B88-0729-4C64-B861-FDE690342889

P31

Q38985873-A11BC6E4-902C-4344-8A08-BF4A81FA4721

P356

Q38985873-8A42D387-018E-4616-BD58-226B8D9247EC

P433

Q38985873-A9AE340D-6CF1-4E5B-9786-C2989F4D0C89

P478

Q38985873-E9091FDF-8514-481C-A4D9-E376DCE8A5C0

P50

Q38985873-4DBD9A97-056D-4FFC-AE0F-CA3EE5E847E7

P577

Q38985873-0C4A8638-15CF-4491-8F10-08457051A9AC

P698

Q38985873-DCEB26E3-923F-4622-BE35-1711628C37D0

P921

Q38985873-BD6F27E6-7D35-4798-90CD-726DE4F3A863

P356

P1433

Annals of Neurology

P1476

Cutaneous malignant melanoma and Parkinson disease: Common pathways?

@en

P2093

Eitan Friedman

http://www.w3.org/2001/XMLSchema#string

Esther Azizi

http://www.w3.org/2001/XMLSchema#string

Shira Flash

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee

Caffeine interaction with glutamate receptor gene GRIN2A: Parkinson's disease in Swedish population

Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans

Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling

The associations between Parkinson's disease and cancer: the plot thickens

The genetics and neuropathology of Parkinson's disease

Alpha-synuclein in Lewy bodies

Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance

The EIF4G1 gene and Parkinson's disease

Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on α-synuclein

P304

811-820

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.24802

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

Rivka Inzelberg

P577

2016-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27761938

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease